CrownBio and Pierre Fabre Partner to Advance Development of Immuno-Oncology Therapies

CrownBio and Pierre Fabre Partner to Advance Development of Immuno-Oncology Therapies

Source: 
CP Wire
snippet: 

Crown Bioscience announced on 6/19/2018 that it has been selected by Pierre Fabre Research Institute as one of their partners to advance their immuno-oncology drug discovery pipeline.